Design, synthesis, anticancer and <i>in silico</i> assessment of 8-piperazinyl caffeinyl-triazolylmethyl hybrid conjugates-Reference-Cited by-同舟云学术

Design, synthesis, anticancer and in silico assessment of 8-piperazinyl caffeinyl-triazolylmethyl hybrid conjugates

Published:2023 Issue:35 Volume:13 Page:24656-24673
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Soltani Rad Mohammad Navid¹²^ORCID,Behrouz Somayeh¹²^ORCID,Shahbazkhani Kiana¹^ORCID,Behrouz Marzieh¹,Zarenezhad Elham³^ORCID,Ghanbariasad Ali⁴

Affiliation:

1. Department of Chemistry, Shiraz University of Technology, Shiraz 71555-313, Iran

2. Medicinal Chemistry Research Laboratory, Novel Technology for Health Research Center, Shiraz University of Technology, Shiraz 71555-313, Iran

3. Non-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran

4. Department of Medical Biotechnology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran

Abstract

Design, synthesis, anticancer, docking, and in silico assessment for 8-piperazinyl caffeinyl-triazolylmethyl hybrid conjugates are explained. These compounds have satisfactory activities against melanoma and breast cancer cell lines.

Funder

Shiraz University of Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/RA/D3RA04817A

Reference54 articles.

1. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

2. https://www.who.int/news-room/fact-sheets/detail/cancer , accessed 1 July 2023

3. https://www.who.int/news-room/fact-sheets/detail/breast-cancer , accessed 1 July 2023

4. Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

5. Melanoma therapeutics: a literature review